Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356317 · ClinicalTrials.gov registry record · Phase 2
Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia
A Phase 2 study of Schizophrenia, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT00356317: Completed Phase 2 study of Schizophrenia, sponsored by University of Miami.
NCT00356317 is a Phase 2 study of Schizophrenia that has completed, run by University of Miami. The registered enrollment target is 400 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00356317, a Phase 2 study of Schizophrenia, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a culturally based family therapy intervention in improving treatment outcome in people with schizophrenia.
Conditions Studied
Interventions
- BEHAVIORAL Culturally informed therapy for schizophrenia (CIT-S)
- BEHAVIORAL Psychoeducation treatment as usual
Study Locations (1)
Florida
- University of Miami - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
What the finished NCT00356317 record still lists
NCT00356317 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher).
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Culturally informed therapy for schizophrenia (CIT-S) is the first listed.
NCT00356317 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00356317 about?
NCT00356317 is a clinical study titled "Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia". This study will evaluate the effectiveness of a culturally based family therapy intervention in improving treatment outcome in people with schizophrenia.
What is the current status of trial NCT00356317?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 400 participants. The study started on 2015-03. Estimated completion is 2015-03.
What conditions does trial NCT00356317 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT00356317?
The interventions under investigation include: Culturally informed therapy for schizophrenia (CIT-S) (BEHAVIORAL), Psychoeducation treatment as usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT00356317?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00356317 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00356317's enrollment target sits among peer trials
400 43rd of 315 higher than 271 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
RECRUITING · Phase 2
-
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
RECRUITING · Phase 2
-
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
RECRUITING · Phase 2
-
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
RECRUITING · Phase 2
-
Study of ALTO-101 in Patients With Schizophrenia
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia